Draganov Pavel, Todorov Spiridon, Todorov Ivan, Karchev Todor, Kalvatchev Zlatko
Laboratory of Molecular Virology, Department of Virology, National Center of Infectious and Parasitic Diseases, 44-A Stoletov Blvd., 1233 Sofia, Bulgaria.
Int J Pediatr Otorhinolaryngol. 2006 Mar;70(3):469-73. doi: 10.1016/j.ijporl.2005.07.018. Epub 2005 Aug 30.
Recurrent respiratory papillomatosis (RRP) is the most common benign neoplasm affecting the larynx and upper respiratory tract in children. Human papillomavirus (HPV) has been implicated as the cause of RRP, most commonly types 6 and 11. The present study was undertaken to evaluate the occurrence of HPV types in a group of patients with juvenile-onset RRP (JORRP).
The study group consists of 23 patients with JORRP. The clinical records of the patients were reviewed, and JORRP was classified as non-aggressive or aggressive. The laryngeal biopsies were taken and investigated for HPV DNA presence using real-time polymerase chain reaction (PCR) with a set of consensus primers (MY09/11). Viral typing was subsequently performed by real-time PCR with type-specific primers for HPV types 6, 11, 16, 18, 31, and 33.
HPV presence was detected in all samples with amplifiable DNA. HPV-11 was revealed in 61.9% of the patients and HPV-6 in 23.8%. Double positivity for HPV types 6 and 11 was identified in 14.3%. Our findings suggest that RRP runs a more aggressive clinical course when HPV-11 infection is present (p=0.0265).
Our results suggest a high frequency of HPV infection in the upper respiratory tract of the studied patients. We believe that the routine application of molecular techniques such as PCR for detection and analysis of HPVs in patients with RRP has diagnostic and prognostic significance.
复发性呼吸道乳头状瘤病(RRP)是影响儿童喉部及上呼吸道的最常见良性肿瘤。人乳头瘤病毒(HPV)被认为是RRP的病因,最常见的是6型和11型。本研究旨在评估一组青少年起病的RRP(JORRP)患者中HPV各型的发生情况。
研究组由23例JORRP患者组成。回顾患者的临床记录,将JORRP分为非侵袭性或侵袭性。采集喉部活检组织,使用一组共有引物(MY09/11)通过实时聚合酶链反应(PCR)检测HPV DNA的存在。随后使用针对HPV 6、11、16、18、31和33型的型特异性引物通过实时PCR进行病毒分型。
在所有可扩增DNA的样本中均检测到HPV存在。61.9%的患者检测到HPV-11,23.8%的患者检测到HPV-6。14.3%的患者HPV 6型和11型呈双重阳性。我们的研究结果表明,存在HPV-11感染时RRP的临床病程更具侵袭性(p = 0.0265)。
我们的结果表明,在所研究患者的上呼吸道中HPV感染频率较高。我们认为,对于RRP患者,常规应用PCR等分子技术检测和分析HPV具有诊断和预后意义。